Quinolones and false-positive urine screening for opiates by immunoassay technology

JAMA

Volumn 286, Issue 24, 2001, Pages 3115-3119

  Baden, Lindsey R ^a,b   Horowitz, Gary ^b   Jacoby, Helen ^b   Eliopoulos, George M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINAFLOXACIN; ENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MORPHINE; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OPIATE DERIVATIVE; PEFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; TROVAFLOXACIN;

ARTICLE; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG SCREENING; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; NORMAL HUMAN; PRIORITY JOURNAL; TECHNOLOGY; URINALYSIS; VOLUNTEER;

EID: 0035956562     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.24.3115     Document Type: Article

References (47)

1. Limited toxicology screening: End of a controversy
2. Results of limited versus comprehensive toxicology screening in a university medical center
3. False-positive EMIT II opiates from ofloxacin
4. A practical approach to determine cutoff concentrations for opiate testing with simultaneous detection of codeine, morphine, and 6-acetylmorphine in urine
5. Mandatory guidelines for federal workplace drug testing programs
6. Changes to the testing cutoff levels for opiates for federal workplace drug testing programs
7. Manadatory guidelines for federal workplace drug testing programs
8. A metabolite of sparfloxacin in urine
9. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects
10. Absence of age and gender effects on the pharmacokinetics of a single 500 mg oral dose of levofloxacin in healthy subjects
11. Antibacterial activity of pefloxacin in the urine during seven days after a single 800 mg oral dose
12. Pharmacokinetics of ciprofloxacin after oral and parenteral administration
13. Ofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
14. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans
15. Singleand multiple-dose phamacokinetics of AM-1155, a new 6-fluro-8-methoxy quinolone, in humans
16. Pharamacokinetics and tissue penetration of enoxacin
17. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration
18. Screening for drugs in forensic blood samples using EMIT urine assays
19. Effect of poppy seed ingestion on the TDx opiates assay
20. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: The Pacific perspective
21. Opiates in poppy seed: Effect on urinalysis results after consumption of poppy seed cake-filling
22. Rifampicin causes falsepositive immunoassay results for urine opiates
23. Concentrations of morphine and codeine in serum and urine after ingestion of poppy seeds
24. Scientific issues in drug testing
25. Falsepositive postmortem EMIT drugs-of-abuse assay due to lactate dehydrogenase and lactate in urine
26. Presence of rifampicin in urine causes crossreactivity with opiates using the KIMS method
27. Pharamacokinetics and quinolones
28. The choice of antibacterial drugs
29. 1998 Guidelines for treatment of sexually transmitted diseases
30. Community-acquired pneumonia in adults: Guidelines for management
31. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis
32. In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis
33. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatments of adults with community-acquired pneumonia
34. Management of tuberculosis in the United States
35. The treatment of multidrug-resistant tuberculosis in Turkey
36. Drugs and vaccines for biological weapons
37. Anthrax as a biological weapon: Medical and public health management
38. Gas chromatographic/mass spectrometric analysis of morphine and codeine in human urine of poppy seed eaters
39. Simultaneous identification and quantification of codeine and morphine in urine by capillary gas chromatography and mass spectroscopy